- Home
- APLM vs SRM Comparison
APLM vs SRM Comparison
Compare APLM & SRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- SRM
- Stock Information
- Founded
- APLM 2016
- SRM 1979
- Country
- APLM United States
- SRM United States
- Employees
- APLM N/A
- SRM N/A
- Industry
- APLM Blank Checks
- SRM
- Sector
- APLM Finance
- SRM
- Exchange
- APLM Nasdaq
- SRM Nasdaq
- Market Cap
- APLM 7.7M
- SRM 9.0M
- IPO Year
- APLM N/A
- SRM 2023
- Fundamental
- Price
- APLM $6.71
- SRM $0.38
- Analyst Decision
- APLM Strong Buy
- SRM
- Analyst Count
- APLM 2
- SRM 0
- Target Price
- APLM $425.00
- SRM N/A
- AVG Volume (30 Days)
- APLM 42.6K
- SRM 220.4K
- Earning Date
- APLM 04-15-2025
- SRM 05-09-2025
- Dividend Yield
- APLM N/A
- SRM N/A
- EPS Growth
- APLM N/A
- SRM N/A
- EPS
- APLM N/A
- SRM N/A
- Revenue
- APLM $2,101,000.00
- SRM $4,311,382.00
- Revenue This Year
- APLM N/A
- SRM N/A
- Revenue Next Year
- APLM N/A
- SRM N/A
- P/E Ratio
- APLM N/A
- SRM N/A
- Revenue Growth
- APLM 70.54
- SRM N/A
- 52 Week Low
- APLM $6.20
- SRM $0.30
- 52 Week High
- APLM $63.00
- SRM $1.85
- Technical
- Relative Strength Index (RSI)
- APLM 43.33
- SRM 40.85
- Support Level
- APLM $6.20
- SRM $0.38
- Resistance Level
- APLM $8.00
- SRM $0.43
- Average True Range (ATR)
- APLM 1.37
- SRM 0.04
- MACD
- APLM -0.18
- SRM 0.00
- Stochastic Oscillator
- APLM 9.44
- SRM 4.10
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.